Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shuangyan Cao

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
International Journal of Rheumatic Diseases|April 29, 2025
Oxidative Phosphorylation Pathway in Ankylosing Spondylitis: Multi-Omics Analysis and Machine LearningYuling Chen, Yuan Xu, Shuangyan Cao, et al.
Plos One|March 15, 2014
MiR-27a targets sFRP1 in hFOB cells to regulate proliferation, apoptosis and differentiationDonggeng Guo, Qiuxia Li, Qing Lv, et al.
Clinical and Experimental Rheumatology|September 20, 2014
Costs and work limitation of patients with ankylosing spondylitis in ChinaLiudan Tu, Jayanti Chamling Rai, Shuangyan Cao, et al.
Biomedical Reports|August 20, 2019
Erratum: Efficacy and safety of loxoprofen hydrogel patch versus loxoprofen tablet in patients with ankylosing spondylitis: A 4-week randomized, open-label studyMeida Fan, Shuangyan Cao, Liudan Tu, et al.
Biomedical Reports|May 30, 2019
Efficacy and safety of loxoprofen hydrogel patch versus loxoprofen tablet in patients with ankylosing spondylitis: A 4-week randomized, open-label studyMeida Fan, Shuangyan Cao, Liudan Tu, et al.
Trials|July 25, 2016
Kunxian capsules in the treatment of patients with ankylosing spondylitis: a randomized placebo-controlled clinical trialQiuxia Li, Li Li, Liqi Bi, et al.
Frontiers in Immunology|March 8, 2021
Serum Metabolomics Signatures Associated With Ankylosing Spondylitis and TNF Inhibitor TherapyJiayong Ou, Min Xiao, Yefei Huang, et al.
Frontiers in Public Health|December 17, 2020
Cost of Illness, Quality of Life, and Work Outcomes in Active Ankylosing Spondylitis Patients Treated With Adalimumab in ChinaLiudan Tu, Ya Xie, Zetao Liao, et al.
Inflammation|June 11, 2014
Higher percentage of CD3⁺CD154⁺ T lymphocytes predicts efficacy of TNF-α inhibitors in active axial SpA patientsZhiming Lin, Qu Lin, Zetao Liao, et al.
Arthritis Research & Therapy|January 6, 2022
Integrative blood-derived epigenetic and transcriptomic analysis reveals the potential regulatory role of DNA methylation in ankylosing spondylitisMin Xiao, Xuqi Zheng, Xiaomin Li, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
International Journal of Rheumatic Diseases|April 29, 2025
Oxidative Phosphorylation Pathway in Ankylosing Spondylitis: Multi-Omics Analysis and Machine LearningYuling Chen, Yuan Xu, Shuangyan Cao, et al.
Plos One|March 15, 2014
MiR-27a targets sFRP1 in hFOB cells to regulate proliferation, apoptosis and differentiationDonggeng Guo, Qiuxia Li, Qing Lv, et al.
Clinical and Experimental Rheumatology|September 20, 2014
Costs and work limitation of patients with ankylosing spondylitis in ChinaLiudan Tu, Jayanti Chamling Rai, Shuangyan Cao, et al.
Biomedical Reports|August 20, 2019
Erratum: Efficacy and safety of loxoprofen hydrogel patch versus loxoprofen tablet in patients with ankylosing spondylitis: A 4-week randomized, open-label studyMeida Fan, Shuangyan Cao, Liudan Tu, et al.
Biomedical Reports|May 30, 2019
Efficacy and safety of loxoprofen hydrogel patch versus loxoprofen tablet in patients with ankylosing spondylitis: A 4-week randomized, open-label studyMeida Fan, Shuangyan Cao, Liudan Tu, et al.
Trials|July 25, 2016
Kunxian capsules in the treatment of patients with ankylosing spondylitis: a randomized placebo-controlled clinical trialQiuxia Li, Li Li, Liqi Bi, et al.
Frontiers in Immunology|March 8, 2021
Serum Metabolomics Signatures Associated With Ankylosing Spondylitis and TNF Inhibitor TherapyJiayong Ou, Min Xiao, Yefei Huang, et al.
Frontiers in Public Health|December 17, 2020
Cost of Illness, Quality of Life, and Work Outcomes in Active Ankylosing Spondylitis Patients Treated With Adalimumab in ChinaLiudan Tu, Ya Xie, Zetao Liao, et al.
Inflammation|June 11, 2014
Higher percentage of CD3⁺CD154⁺ T lymphocytes predicts efficacy of TNF-α inhibitors in active axial SpA patientsZhiming Lin, Qu Lin, Zetao Liao, et al.
Arthritis Research & Therapy|January 6, 2022
Integrative blood-derived epigenetic and transcriptomic analysis reveals the potential regulatory role of DNA methylation in ankylosing spondylitisMin Xiao, Xuqi Zheng, Xiaomin Li, et al.
Pageof 4